USPTO serial 79431050
OLIGOCREATOR
Reviewed by CopyMark Law Group
Status 645Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- LAVACHE, LINDA M
- Law office
- TMEG LAW OFFICE 106
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with OLIGOCREATOR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Scientific research services in the fields of biochemistry, nucleic acids, and bioinformatics, excluding the field of cell culture product, in particular molecular biology techniques, especially antisense techniques; design of pharmaceutical active ingredients by the use of bioinformatics techniques; development of pharmaceutical products by the use of bioinformatics techniques being testing and diagnostic procedures; bioinformatic services for scientific research purposes in the pharmaceutical and biotechnological industry, namely, computational design and optimization of oligonucleotide sequences, sequence analysis of nucleic acids, target identification and validation using bioinformatic methods, in silico screening and prediction of efficacy, safety and off-target effects of nucleic acid therapeutics, analysis of gene expression and multiomics data, integration and analysis of biological data sets, selection of candidate oligonucleotides based on computational and experimental data, application of artificial intelligence and machine learning for drug discovery and sequence optimization, and scientific and technological services in the field of oligonucleotide research and nucleic acid therapeutics; evaluation of pharmaceutical products with respect to their safety and efficacy to assure compliance with industry standards | ACTIVE | — |
| 044 | Consultancy services to third parties in the field of biochemistry and nucleic acids and bioinformatics, namely, using antisense technology for the development of pharmaceutical products; consultancy services to third parties in the field of the evaluation of safety and efficacy of pharmaceuticals | ACTIVE | — |
| 045 | Licensing of industrial property rights arising from scientific research services in the fields of biochemistry, nucleic acids, and bioinformatics, excluding the field of cell culture products, in particular molecular biology techniques, especially antisense techniques; licensing of industrial property rights arising from the design of pharmaceutical active ingredients using molecular biology techniques, especially antisense techniques; licensing of industrial property rights arising from the development of pharmaceutical products using molecular biology techniques being testing and diagnostic procedures; licensing of industrial property rights arising from bioinformatic services for the pharmaceutical and biotechnological industry; licensing of industrial property rights arising from the services for evaluating the efficacy and safety of pharmaceutical products | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 19, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 19, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 19, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 16, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 16, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 16, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 15, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 28, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 28, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 9, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 8, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 30, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 29, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 29, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 28, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |